Literature DB >> 22236834

Development of a clinical global impression scale for fatigue.

Steven D Targum1, Howard Hassman, Maria Pinho, Maurizio Fava.   

Abstract

Physical, cognitive, and affective components of fatigue are often associated with depression and other Axis I psychiatric disorders. We developed two, single item global assessment scales to specifically evaluate symptoms of fatigue. 101 subjects visiting a clinical trial site consented to participate in this reliability and validity study. Diagnoses included Major Depressive Disorder, Bipolar disorder, and schizophrenia. There were two clinic visits during which the modified Clinician and Patient Impressions of Fatigue rating instruments were administered in conjunction with the MGH cognitive and physical functioning questionnaire (MGH-CPFQ), a validated patient-rated 7-item scale. CGI-Severity and PGI-Severity for fatigue were well correlated at two separate visits (p < 0.00005). At visit 1, the mean CGI-S for fatigue was 3.33 ± 1.53 (SD) and the PGI-S for fatigue was 3.57 ± 1.70 (r = 0.75; p = 0.000). At visit 1, the total MGH-CPFQ was 21.66 ± 6.92. Both CGI-S and PGI-S measures for fatigue were highly correlated with the MGH-CPFQ: CGI-S (r = 076; p < 0.00005); PGI-S (r = 0.62; p < 0.00005). Both the PGI-S and CGI-S for fatigue revealed temporal stability and convergent validity for the MGH-CPFQ (r = 0.83 for CGI-S and 0.73 for PGI-S). There was high internal consistency between the two independent CGI raters at visit 2 as demonstrated by a kappa statistic = 0.971 (CGI-S) and 0.868 (CGI-I) and Cronbach's alpha = 0.998 (CGI-S) and 0.941 (CGI-I). As shown here, the modified CGI and PGI instruments for fatigue are reliable measures of fatigue and both measures are validated with the MGH-CPFQ instrument.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22236834     DOI: 10.1016/j.jpsychires.2011.12.001

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  9 in total

Review 1.  Efficacy of Magnetic Therapy in Pain Reduction in Patients with Chronic Pelvic Pain: A Systematic Review.

Authors:  Alicia María de Pedro Negri; María Jesús Ruiz Prieto; Esther Díaz-Mohedo; Rocío Martín-Valero
Journal:  Int J Environ Res Public Health       Date:  2022-05-10       Impact factor: 4.614

2.  Development of a clinician-administered National Institutes of Health-Brief Fatigue Inventory: A measure of fatigue in the context of depressive disorders.

Authors:  Leorey N Saligan; David A Luckenbaugh; Elizabeth E Slonena; Rodrigo Machado-Vieira; Carlos A Zarate
Journal:  J Psychiatr Res       Date:  2015-06-24       Impact factor: 4.791

3.  A psychometric study of the multidimensional fatigue inventory to assess fatigue in patients with schizophrenia spectrum disorders.

Authors:  Lena Hedlund; Amanda Lundvik Gyllensten; Lars Hansson
Journal:  Community Ment Health J       Date:  2014-06-28

4.  Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial.

Authors:  Maju Mathews; Carl Gommoll; Dalei Chen; Rene Nunez; Arif Khan
Journal:  Int Clin Psychopharmacol       Date:  2015-03       Impact factor: 1.659

5.  Efficacy and safety of Xiangsha Liujunzi granules for functional dyspepsia: A multi-center randomized double-blind placebo-controlled clinical study.

Authors:  Lin Lv; Feng-Yun Wang; Xiang-Xue Ma; Zhen-Hua Li; Sui-Ping Huang; Zhao-Hong Shi; Hai-Jie Ji; Li-Qun Bian; Bei-Hua Zhang; Ting Chen; Xiao-Lan Yin; Xu-Dong Tang
Journal:  World J Gastroenterol       Date:  2017-08-14       Impact factor: 5.742

6.  Transdiagnostic Clinical Global Impression Scoring for Routine Clinical Settings.

Authors:  Boadie W Dunlop; Jaclyn Gray; Mark H Rapaport
Journal:  Behav Sci (Basel)       Date:  2017-06-27

7.  Assessment of the efficacy of a fatigue management therapy in schizophrenia: study protocol for a randomized, controlled multi-centered study (ENERGY).

Authors:  Stéphane Raffard; Nicolas Rainteau; Sophie Bayard; Yasmine Laraki; Joanna Norton; Delphine Capdevielle
Journal:  Trials       Date:  2020-09-17       Impact factor: 2.279

8.  A structured interview guide for global impressions: increasing reliability and scoring accuracy for CNS trials.

Authors:  Steven D Targum; Celine Houser; Joanne Northcutt; Jessica A Little; Andrew J Cutler; David P Walling
Journal:  Ann Gen Psychiatry       Date:  2013-01-31       Impact factor: 3.455

Review 9.  Trends in (not) using scales in major depression: A categorization and clinical orientation.

Authors:  Koen Demyttenaere; Liesbeth Jaspers
Journal:  Eur Psychiatry       Date:  2020-09-23       Impact factor: 5.361

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.